These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8952593)

  • 1. Chronic renal neuroadrenergic hypertension is associated with increased renal norepinephrine sensitivity and volume contraction.
    Plato CF; Osborn JL
    Hypertension; 1996 Dec; 28(6):1034-40. PubMed ID: 8952593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs.
    Katholi RE; Carey RM; Ayers CR; Vaughan ED; Yancey MR; Morton CL
    Circ Res; 1977 May; 40(5 Suppl 1):I118-26. PubMed ID: 870220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term increases in renal sympathetic nerve activity and hypertension.
    Osborn JL; Plato CF; Gordin E; He XR
    Clin Exp Pharmacol Physiol; 1997 Jan; 24(1):72-6. PubMed ID: 9043809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs.
    Cowley AW; Lohmeier TE
    Hypertension; 1979; 1(6):549-58. PubMed ID: 396248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog.
    Katholi RE; Whitlow PL; Hageman GR; Woods WT
    J Hypertens; 1984 Aug; 2(4):349-59. PubMed ID: 6397533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension induced by chronic renal adrenergic stimulation is angiotensin dependent.
    Reinhart GA; Lohmeier TE; Hord CE
    Hypertension; 1995 May; 25(5):940-9. PubMed ID: 7737731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoconstriction and hypersensitivity to vasoactive substances after acute volume expansion in dogs.
    Otsuka A; Ogihara T; Kohara K; Mikami H; Katahira K; Tsunetoshi T; Kumahara Y
    Hypertension; 1988 Jul; 12(1):59-66. PubMed ID: 2456268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and circulatory responses to chronically controlled increments in right atrial pressure.
    Shin Y; Lohmeier TE; Hester RL; Kivlighn SD; Smith MJ
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1176-87. PubMed ID: 1835308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of renal function by angiotensin during chronic adrenergic stimulation.
    Lohmeier TE; Yang HM
    Hypertension; 1991 Mar; 17(3):278-87. PubMed ID: 1999358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats.
    Kleinjans JC; Smits JF; van Essen H; Kasbergen CM; Struyker Boudier HA
    Hypertension; 1984; 6(5):689-99. PubMed ID: 6500674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog.
    Oliver JA; Pinto J; Sciacca RR; Cannon PJ
    J Clin Invest; 1980 Oct; 66(4):748-56. PubMed ID: 6999033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
    Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
    Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
    Troughton RW; Lewis LK; Yandle TG; Richards AM; Nicholls MG
    Hypertension; 2000 Oct; 36(4):588-93. PubMed ID: 11040240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of escape from sodium retention during angiotensin II hypertension.
    Hall JE; Granger JP; Hester RL; Coleman TG; Smith MJ; Cross RB
    Am J Physiol; 1984 May; 246(5 Pt 2):F627-34. PubMed ID: 6720967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of endogenous angiotensin on the renovascular response to norepinephrine.
    Yang HM; Lohmeier TE
    Hypertension; 1993 May; 21(5):695-703. PubMed ID: 8491504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure.
    Lohmeier TE; Hildebrandt DA; Dwyer TM; Barrett AM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Feb; 49(2):373-9. PubMed ID: 17159083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery.
    Anand IS; Chandrashekhar Y; Ferrari R; Sarma R; Guleria R; Jindal SK; Wahi PL; Poole-Wilson PA; Harris P
    Circulation; 1992 Jul; 86(1):12-21. PubMed ID: 1617764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic effects of vasopressin on plasma renin activity in sodium-restricted dogs.
    Merrill DC; Cowley AW
    Am J Physiol; 1986 Mar; 250(3 Pt 2):F460-9. PubMed ID: 3513620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure.
    Miller WL; Edwards BS; Zimmerman RS; Burnett JC
    Circ Res; 1990 Jan; 66(1):76-83. PubMed ID: 2136813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.